Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

DXTR / Dextera Surgical Inc. FORM NT 10-Q

2018-02-15 sec.gov
crdc20180214_nt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 12b-25   Commission File Number: 000-51772 CUSIP Number: 252366109   NOTIFICATION OF LATE FILING   (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR   For Period Ended:   December 31, 2017                                                ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Rep

DXTR / Dextera Surgical Inc. FORM 8-K (Current Report)

2018-01-26 sec.gov
crdc20180125_8k.htm     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): January 24, 2018   Dextera Surgical Inc. (Exact Name of Registrant as Specified in its Charter)           Delaware (State or Other Jurisdiction of Incorporation)   000-51772 (Commission File Number)   94-3287832 (IRS Employer Identification No.

DXTR / Dextera Surgical Inc. EXHIBIT 10.2

2017-12-15 sec.gov
ex_102189.htm Exhibit 10.2   LINE OF CREDIT NOTE     $1,500,000.00 Date: December 15, 2017   FOR VALUE RECEIVED, DEXTERA SURGICAL, INC., a Delaware corporation formerly known as “Cardica, Inc.” (the “Maker”), promises to pay to the order of AESCULAP, INC., a California corporation, or its designee (the “Payee”), at its address at 3773 Corporate Parkway, Center Valley, PA 18034 or at such other place as Payee may from time to time designate in writing, the principal sum of One Million Five Hundre

DXTR / Dextera Surgical Inc. EXHIBIT 10.1

2017-12-15 sec.gov
ex_102180.htm Exhibit 10.1               POST-PETITION LOAN AND SECURITY AGREEMENT   DATED AS OF   December 15, 2017   By and Between   DEXTERA SURGICAL INC.,   As Borrower,   And   AESCULAP, INC., or its designee   as Lender               TABLE OF CONTENTS   Page   SECTION 1. DEFINITIONS 1     1.1 General Provisions 1 1.2 Defined Terms 2     SECTION 2. AMOUNT AND TERMS OF LOAN 10     2.1 Line of Credit 10 2.

DXTR / Dextera Surgical Inc. EXHIBIT 2.1

2017-12-15 sec.gov
ex_102150.htm Exhibit 2.1   EXECUTION COPY             ASSET PURCHASE AGREEMENT   dated as of   December 11, 2017   by and between DEXTERA SURGICAL INC.,   as Seller,   and   AESCULAP, INC.   as Buyer                   TABLE OF CONTENTS   TABLE OF CONTENTS I     ARTICLE I DEFINITIONS 1     Section 1.1. Defined Terms 1 Section 1.2. Interpretation and Construction 11     ARTICLE II AGREEMENTS TO SELL AND PURCHASE; RELATED MATTERS 12     Section 2.

DXTR / Dextera Surgical Inc. FORM 8-K (Current Report)

2017-12-15 sec.gov
crdc20171215_8k.htm   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): December 11, 2017   Dextera Surgical Inc. (Exact Name of Registrant as Specified in its Charter)       Delaware (State or Other Jurisdiction of Incorporation) 000-51772 (Commission File Number) 94-3287832 (IRS Employer Identification No.

BRIEF-Dextera Surgical Says Nasdaq Has Determined To Delist Co's Common Stock

2017-12-12 reuters
* DEXTERA SURGICAL - ON DEC 11, CO RECEIVED FROM NASDAQ LETTER NOTIFYING CO THAT NASDAQ HAS DETERMINED TO DELIST CO‘S COMMON STOCK FROM NASDAQ (86-0)

DXTR / Dextera Surgical Inc. FORM 8-K (Current Report)

2017-12-12 sec.gov
crdc20171211_8k.htm   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): December 11, 2017   Dextera Surgical Inc. (Exact Name of Registrant as Specified in its Charter)           Delaware (State or Other Jurisdiction of Incorporation)   000-51772 (Commission File Number)   94-3287832 (IRS Employer Identification No.

DXTR / Dextera Surgical Inc. FORM 8-K (Current Report)

2017-11-29 sec.gov
crdc20171129_8k.htm   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): November 29, 2017   Dextera Surgical Inc. (Exact Name of Registrant as Specified in its Charter)           Delaware (State or Other Jurisdiction of Incorporation)   000-51772 (Commission File Number)   94-3287832 (IRS Employer Identification No.

BRIEF-Dextera Surgical reports first quarter financial results

2017-11-09 reuters
* Dextera Surgical Inc - ‍total product sales were approximately $0.6 million for fiscal 2018 Q1 compared with $0.4 million for same quarter of fiscal 2017​ Source text for Eikon: Further company coverage: (86-3)

DXTR / Dextera Surgical Inc. EXHIBIT 99.1

2017-11-09 sec.gov
ex_99960.htm Exhibit 99.1       DEXTERA SURGICAL REPORTS FISCAL 2018 FIRST QUARTER FINANCIAL RESULTS     REDWOOD CITY, Calif. – November 9, 2017 – Dextera Surgical Inc. (Nasdaq: DXTR), a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced financial results for its fiscal first quarter ended September 30, 2017.   “We are making progress toward resolving our component and raw material supply challenges and expect to begin shipping reloads in December and to resolv

DXTR / Dextera Surgical Inc. FORM 8-K (Current Report)

2017-11-09 sec.gov
crdc20171109_8k.htm       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): November 9, 2017   Dextera Surgical Inc. (Exact Name of Registrant as Specified in its Charter)   Delaware (State or Other Jurisdiction of Incorporation) 000-51772 (Commission File Number) 94-3287832 (IRS Employer Identification No.

DXTR / Dextera Surgical Inc. EXHIBIT 32.1

2017-11-09 sec.gov
ex_99874.htm Exhibit 32.1 CERTIFICATION     Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Julian Nikolchev, Chief Executive Officer of Dextera Surgical Inc. (the "Company"), and Robert Y. Newell, Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:   1.

DXTR / Dextera Surgical Inc. EXHIBIT 31.2

2017-11-09 sec.gov
ex_99873.htm Exhibit 31.2   CERTIFICATION     I, Robert Y. Newell, certify that:   1. I have reviewed this Form 10-Q of Dextera Surgical Inc.;   2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;   3.

DXTR / Dextera Surgical Inc. EXHIBIT 31.1

2017-11-09 sec.gov
ex_99872.htm Exhibit 31.1 CERTIFICATION     I, Julian Nikolchev, certify that:   1. I have reviewed this Form 10-Q of Dextera Surgical Inc.;   2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;   3.


DXTR : Dextera Surgical Stock Analysis and Research Report

Dextera Surgical is commercializing and developing the MicroCutter 5/80TM stapler based on its proprietary ‘‘staple-on-a-strip’’ technology intended for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its proprietary ‘‘staple-on-a-strip’’ technology enables it to develop products with innovative features such as consistent staple forms, significantly reduced tool shaft diameter and increased articulation. Together these advances in stapler design enable surgeons to perform procedures on a broader array of patients and to develop procedural methods previously unattainable with existing products in the market. The MicroCutter 5/80, which is currently commercially available, is a cartridge-based stapler device with a 5 millimeter shaft diameter, 80 degrees of articulation, and a 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union, or EU, for a broader range of specified indications of use. Dextera esti...

Click for full article
CUSIP: 14141R101